Published in JAMA on July 03, 1996
Screening for breast cancer. JAMA (2005) 4.56
International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75
Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst (2002) 2.71
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res (2005) 2.68
Photoacoustic angiography of the breast. Med Phys (2010) 2.26
Health status and mammography use among older women. J Gen Intern Med (1998) 1.29
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med (2005) 1.25
Differences in the quality of care for women with an abnormal mammogram or breast complaint. J Gen Intern Med (2000) 1.25
Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One (2007) 1.22
Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med (2001) 1.22
Effects of age on the detection and management of breast cancer. Cancers (Basel) (2015) 0.94
Mammography rescreening among older California women. Health Care Financ Rev (2001) 0.92
Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors. BMC Med Genomics (2011) 0.91
How does age affect baseline screening mammography performance measures? A decision model. BMC Med Inform Decis Mak (2008) 0.85
A genetic strategy for combined screening and localized imaging of breast cancer. Mol Imaging Biol (2011) 0.84
Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions. Cancer Imaging (2010) 0.84
Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women. BMC Womens Health (2006) 0.80
Detection of microcalcifications by characteristic magnetic susceptibility effects using MR phase image cross-correlation analysis. Med Phys (2015) 0.78
Value of Apparent Diffusion Coefficient Values in Differentiating Malignant and Benign Breast Lesions. Balkan Med J (2016) 0.77
Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection. Oncotarget (2015) 0.76
Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast. BMC Womens Health (2016) 0.76
Screening mammography and risk of breast cancer. JAMA (1996) 0.75
Strategies for improving sensitivity of screening mammography for women aged 40 to 49 years. JAMA (1996) 0.75
Computer-Aided Reporting of Chest Radiographs: Efficient and Effective Screening in the Value-Based Imaging Era. J Digit Imaging (2017) 0.75
Left ventricular pseudoaneurysm. J Am Coll Cardiol (1998) 8.81
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA (1996) 6.53
Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA (1996) 4.89
Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05
Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology (2000) 4.02
Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol (1990) 3.98
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA (1996) 3.54
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA (1998) 3.32
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol (1999) 3.19
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
Positive predictive value of screening mammography by age and family history of breast cancer. JAMA (1993) 2.95
Hysterectomy and urinary incontinence: a systematic review. Lancet (2000) 2.89
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med (2000) 2.75
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA (1995) 2.69
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
Appropriate role of core breast biopsy in the management of probably benign lesions. Radiology (1993) 2.44
Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med (1996) 2.36
Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. Radiology (2001) 2.36
Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol (1995) 2.30
Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol (1999) 2.29
Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol (1999) 2.20
Modelling theophylline response in individual patients with chronic bronchitis. Br J Clin Pharmacol (1981) 2.20
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med (2000) 2.09
Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging (2001) 1.89
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res (2000) 1.81
Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol (1995) 1.78
Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health (1998) 1.78
Does cigarette smoking make you ugly and old? Am J Epidemiol (1992) 1.76
Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer (1996) 1.76
Baseline screening mammography: one vs two views per breast. AJR Am J Roentgenol (1986) 1.69
Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst (1993) 1.68
Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr (1997) 1.68
Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc (1998) 1.66
Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation (2001) 1.61
Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol (1996) 1.59
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
Men with sexually transmitted diseases in Bangkok: where do they go for treatment and why? AIDS (1997) 1.56
Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol (2000) 1.55
Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. Br J Clin Pharmacol (1981) 1.53
Canadian National Breast Screening Study. AJR Am J Roentgenol (1990) 1.51
Efficacy of step-oblique mammography for confirmation and localization of densities seen on only one standard mammographic view. AJR Am J Roentgenol (2000) 1.45
Risk of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment with theophylline. Br Med J (Clin Res Ed) (1984) 1.45
Acceptability of periodic follow-up as an alternative to biopsy for mammographically detected lesions interpreted as probably benign. Radiology (1989) 1.44
The lumpy breast. West J Med (1988) 1.43
Predictors of visits to commercial sex workers by male attendees at sexually transmitted disease clinics in southern Vietnam. AIDS (1999) 1.43
Paradoxical vocal cord motion: an unusual cause of stridor in the recovery room. Anesthesiology (1993) 1.41
The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR Am J Roentgenol (1995) 1.41
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. Radiology (2000) 1.41
Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer (1995) 1.39
Carpal tunnel syndrome. West J Med (1988) 1.38
Breast calcifications: mammographic evaluation. Radiology (1986) 1.38
Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial. West J Med (2001) 1.35
Clinical presentation of infection in granulocytopenic patients. Arch Intern Med (1975) 1.33
Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr (1997) 1.29
Mammographic features of 300 consecutive nonpalpable breast cancers. AJR Am J Roentgenol (1986) 1.29
Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients. Anesth Analg (2005) 1.29
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28
The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med (1993) 1.27
Further experience with microfocal spot magnification mammography in the assessment of clustered breast microcalcifications. Radiology (1980) 1.26
Antibiotics in acute bronchitis: a meta-analysis. Am J Med (1999) 1.24
American College of Radiology guidelines for breast cancer screening. AJR Am J Roentgenol (1998) 1.24
Periodontal effects associated with the use of smokeless tobacco. J Periodontol (1990) 1.17
A rebuttal to the tobacco industry's paper, "Cigarette Smoke and the Nonsmoker". J Public Health Policy (1984) 1.15
Pneumonia in acute leukemia. Ann Intern Med (1973) 1.12
Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst (1997) 1.11
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol (1998) 1.11
Pneumonectomy for drug resistant mycobacterium malmoense. Thorax (1983) 1.11
Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol (2001) 1.10
Sedimented calcium in benign breast cysts: the full spectrum of mammographic presentations. AJR Am J Roentgenol (1989) 1.10
The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2001) 1.09
Forty-something breast screening. Science (1997) 1.09